SCM
BNTX icon

Sterling Capital Management’s BioNTech BNTX Stock Holding History

Sterling Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Hold
134
– – ﹤0.01% 2108
2026
Q1 		$11.9K Sell
134
-1
-0.7% -$103 ﹤0.01% 2282
2025
Q4 		$12.9K Hold
135
– – ﹤0.01% 2483
2025
Q3 		$13.3K Hold
135
– – ﹤0.01% 2337
2025
Q2 		$14.4K Hold
135
– – ﹤0.01% 1927
2025
Q1 		$12.3K Hold
135
– – ﹤0.01% 1801
2024
Q4 		$15.4K Hold
135
– – ﹤0.01% 1964
2024
Q3 		$16K Buy
+135
New +$12.4K ﹤0.01% 1492

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Sterling Capital Management's BNTX Position: Q2 2026 in Review

Sterling Capital Management held its BioNTech (BNTX) position steady in Q2 2026 at 134 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

Sterling Capital Management first reported a position in BNTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $16K in Q3 2024. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Sterling Capital Management held 134 shares of BioNTech worth $12.5K as of Q2 2026.
  • Sterling Capital Management left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2108 holding.
  • Sterling Capital Management first reported a position in BioNTech in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's BioNTech position peaked at $16K in Q3 2024.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.